New Zealand markets closed

Mayne Pharma Group Ltd (HG6.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
2.8000+0.0800 (+2.94%)
At close: 07:30PM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Assets
Current assets
Cash
Cash and cash equivalents
92,616
96,672
97,980
137,785
-
Other short-term investments
127,526
-
-
-
-
Total cash
220,142
96,672
97,980
137,785
-
Net receivables
186,821
260,028
173,938
192,612
-
Inventory
82,700
108,908
102,510
93,997
-
Other current assets
28,173
12,134
16,208
443
-
Total current assets
553,629
511,618
416,528
490,947
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
103,806
347,262
318,588
321,863
-
Accumulated depreciation
-52,324
-121,407
-96,993
-83,619
-
Net property, plant and equipment
51,482
225,855
221,595
238,244
-
Goodwill
-
22,127
20,346
22,174
21,725
Intangible assets
617,264
405,387
615,808
940,117
-
Other long-term assets
2,320
4,450
4,108
-
-
Total non-current assets
693,725
776,308
1,046,656
1,334,233
-
Total assets
1,247,354
1,287,926
1,463,184
1,825,180
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
10,810
405,367
51,158
44,836
-
Accounts payable
32,027
63,571
42,363
29,842
-
Other current liabilities
22,854
17,713
36,080
49,293
-
Total current liabilities
310,959
610,421
222,527
219,253
-
Non-current liabilities
Long-term debt
28,480
-
285,802
344,420
318,501
Deferred tax liabilities
7,799
6,031
13,460
28,981
-
Other long-term liabilities
260,856
108,401
161,838
180,226
-
Total non-current liabilities
302,035
120,385
469,078
563,614
-
Total liabilities
612,994
730,806
691,605
782,867
-
Stockholders' equity
Common stock
1,233,692
1,238,537
1,238,537
1,238,584
-
Retained earnings
-769,770
-822,406
-559,063
-350,640
-
Accumulated other comprehensive income
170,438
148,642
88,883
149,603
-
Total stockholders' equity
634,360
564,773
768,357
1,037,547
-
Total liabilities and stockholders' equity
1,247,354
1,287,926
1,463,184
1,825,180
-